PTHL Stock Summary and Trading Ideas (Pheton Holdings - Class A | NASDAQ:PTHL)

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings - Class A trades on the NASDAQ stock market under the symbol PTHL.

As of December 15, 2025, PTHL stock price was flat at $0.53 with 67,521 million shares trading.

PTHL has a beta of 3.77, meaning it tends to be more sensitive to market movements. PTHL has a correlation of 0.03 to the broad based SPY ETF.

PTHL has a market cap of $9.01 million. This is considered a Sub-Micro Cap stock.

PTHL has underperformed the market in the last year with a price return of -86.8% while the SPY ETF gained +13.8%. PTHL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -41.6% and -14.8%, respectively, while the SPY returned +3.8% and -0.4%, respectively.

PTHL support price is $.50 and resistance is $.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PTHL shares will trade within this expected range on the day.